Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study.
about
Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based TherapyLupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosusCirculating soluble adhesion molecules in ANCA-associated vasculitis.Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.Endothelial dysfunction in chronic inflammatory diseasesUrine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis.Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.Neurologic manifestations of systemic lupus erythematosus in children and adults.Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model.Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice.Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLEAberrant regulation of the integrin very late antigen-4 in systemic lupus erythematosus.17β estradiol regulates adhesion molecule expression in mesangial cells during glomerulonephritis.Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus.Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as a Biomarker in the Mouse Model of Experimental Autoimmune Myocarditis (EAM)Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1.Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritisUrinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.Evaluation of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Discriminating between Active and Non-Active Systemic Lupus ErythematosusThe search for lupus biomarkers.Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations.Global trends, potential mechanisms and early detection of organ damage in SLE.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.The Usefulness of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Monitoring Systemic Lupus Erythematosus Disease Activity.Lupus nephritis: the value of biochemical and immunological monitoring of disease activity.Biochemistry of nitric oxidePredictive biological markers of systemic lupus erythematosus flares: a systematic literature review.Levels of soluble E-selectin in patients with active Behcet's disease.Soluble receptors and cytokine antagonists in human milk.Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis.Urine angiostatin and VCAM-1 surpass conventional metrics in predicting elevated renal pathology activity indices in lupus nephritis.Relationship between lupus nephritis activity and the serum level of soluble VCAM-1.Identification and characterization of a calreticulin-binding nuclear protein as histone (H1), an autoantigen in systemic lupus erythematosus.Soluble E-selectin correlates with disease activity in cyclosporin A-treated patients with atopic dermatitis.Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot Study.Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus.
P2860
Q26742060-690C27DE-44AA-4A55-B69D-55AD0FB123A2Q28344929-6CFABA03-6232-4220-9D99-7CD6214EE008Q31832551-C2E80213-79CB-42EC-9D2D-73D436C587D2Q33387473-DF1EA56A-E97E-4EEC-B35C-65711F40317FQ34072179-339C4B68-E919-494D-8E74-D57D970FE246Q34082546-DC9C46AC-38FB-4E42-B897-6B5972E915F6Q34230589-41880D65-6C35-4D1D-8D6D-DF7B365DB759Q34310715-56F01CAD-2BFD-47BE-9983-A1095B3952CFQ34401933-97754397-7D21-48D2-8307-44089E529801Q34442812-099832B6-1897-4F3F-87F7-51926B3E05E2Q34512778-DE5345F5-0F51-4F30-AA3E-38F75DB1DFB2Q35565755-5B42099C-D951-41EF-A141-7B6914F63117Q35738559-537C9A9A-8FF9-41F9-A34F-13279B7F6F53Q36085852-44EA7C92-5A68-4CB1-9071-79D079715B14Q36097614-DD04F222-1680-457C-995A-A7DBB4EDDD16Q36312962-5D01AC43-BF6A-496A-A5B9-965EAE7660D6Q36477458-626CB459-2C61-40FF-87C2-D24A3CF43D99Q36633311-644B3C41-5709-49FD-872B-3A43054044B7Q36713542-1D5413D4-BADB-4F8F-86E3-6A870E5A91D5Q37069721-68C4ABD2-63B3-4BEF-BBDF-54CDF2C2DAB5Q37308042-C14BAA9B-E3E6-4F2E-87F3-5B063462DFF1Q37363894-759A9CA2-8C81-4DB0-A3A4-A5ECCF10CC60Q38066385-955E3274-BECE-4866-9B7A-F5A30DF207DDQ38162490-93B41BFD-FAB6-447B-88DB-58D952086986Q38247180-87D5E098-AF77-4026-92B5-CB2A7559F6BBQ39646545-EB5F3583-9CC4-4399-B777-086DA594BB1BQ41197807-7745EBEC-0637-459C-BE0F-F54FEC82B966Q41850306-190AC23C-DE3B-45A9-BE05-A42129FDA8F4Q42634173-08324D74-4154-44EB-96A4-F42151252709Q45037572-8A56C3B9-1327-4FDA-85C9-27914A41F4A7Q45101752-9F78848C-6D59-4CAD-A380-A1FC1A0937E9Q45904209-270DAF68-019A-4CD7-84A3-32EAB5BE11B7Q47405187-657800EA-1003-4A0C-ABE4-A19157E3A734Q47719646-E6A323DF-6CA9-4F78-BA66-7DDAA930B561Q48362764-25AE96D3-1A25-4CF5-9270-732FA52AB54EQ48767208-83E3C907-E1C0-42F1-B376-98E8D29F135BQ49211512-8EC5E057-9D49-4FD3-99DC-B482D3D04448Q50329525-18719672-DF72-485D-92F3-87768C5B1A26Q51076609-74A3537D-E7B2-450D-B10F-87B6C9F1024BQ52968820-C764A8EE-7964-4A5A-8BB7-880DD9BE738E
P2860
Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Levels of soluble VCAM-1, solu ...... a long term prospective study.
@en
type
label
Levels of soluble VCAM-1, solu ...... a long term prospective study.
@en
prefLabel
Levels of soluble VCAM-1, solu ...... a long term prospective study.
@en
P2093
P1476
Levels of soluble VCAM-1, solu ...... a long term prospective study.
@en
P2093
Huitema MG
Kallenberg CG
Limburg PC
P2860
P304
P356
10.1111/J.1365-2249.1994.TB06107.X
P577
1994-09-01T00:00:00Z